The largest and longest study of the obesity drug Wegovy has shown people maintain significant weight loss for at least four ...
Users receiving weekly injections saw their weight fall, plateau, and stabilize over the course of a four-year trial—but it’s ...
New research has found weight loss drug Wegovy can produce significant results for at least four years of treatment. The drug has also been found to deliver cardiovascular benefits in overweight ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found.
In the semaglutide group, weight loss continued to week 65 and was sustained for 4 years, with participants' losing on average 10.2% of their body weight and 7.7cm from their waistline, compared ...
The benefit-harm balance of initiating Glucagon-like Peptide-1 (GLP-1) receptor agonists (RAs) versus a placebo intervention.
The blockbuster weight-loss drug Wegovy can help people sustain their weight-loss triumphs for several years and also may provide cardiovascular benefits, according to two new analyses of data ...
From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by ...
The diabetes and weight loss prescription drug market shows no sign of thinning out anytime soon. Tackling the obesity problem head-on has been tried before with fad diets and low-quality, low ...
Opinions expressed by Forbes Contributors are their own. I write about healthcare policy, with an emphasis on Rx drugs. Copenhagen, Denmark: Packages of the weight loss drug "Wegovy" from the ...
Opinions expressed by Forbes Contributors are their own. I write about healthcare policy, with an emphasis on Rx drugs. Amid increased concern about the costs of using glucagon-like peptide 1 ...